Hepatic steatosis in patients with schizophrenia: a clinical cross-sectional study.
Anna Sofie Kaestel AarøeKatrine Odgaard MaengRagnhild Leifsdottir JacobsenSvend Eggert JensenClaus GraffChristoffer PolcwiartekEsben Bolvig MarkAnja Borgen DalsgaardCamilla Tranekaer HostrupPernille Veiss-PedersenJens Brøndum FrøkjaerJørgen AagaardRené Ernst NielsenPublished in: Nordic journal of psychiatry (2021)
Higher ALT and the presence of metabolic syndrome were associated with HS in patients with schizophrenia utilizing multivariable analysis. The findings suggest that risk factors for HS are similar in both the general population and in patients with schizophrenia.